Mesothelioma, Malignant Pleural Clinical Trials
2 recruiting trials for Mesothelioma, Malignant Pleural. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT05188859
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
This study is a single-arm, open-lable, single-center phase II clinical trial for patients with advanced or metastatic pleural mesothelioma. The aim of this study was to observe...
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesEnrolling: 292 locations
RECRUITINGNCT06886672
Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE VariaTionS
Malignant pleural mesothelioma (MPM) is a rare and aggressive neoplasm of the pleural mesothelium, mainly associated to asbestos exposure, still lacking effective therapies....
Sponsor: Fondazione IRCCS Policlinico San Matteo di PaviaEnrolling: 602 locations